|
TDP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.93819999996892E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.81769999999726E-05 |
| Normal-vs-Stage2 |
1.33680000402592E-08 |
| Normal-vs-Stage3 |
1.8609999999919E-05 |
| Normal-vs-Stage4 |
6.37199999999893E-05 |
| Stage1-vs-Stage2 |
2.120200E-03 |
| Stage1-vs-Stage3 |
6.381600E-01 |
| Stage1-vs-Stage4 |
3.920400E-01 |
| Stage2-vs-Stage3 |
2.076300E-02 |
| Stage2-vs-Stage4 |
7.600500E-02 |
| Stage3-vs-Stage4 |
6.818400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.24899999998096E-06 |
| Normal-vs-AfricanAmerican |
1.799800E-03 |
| Normal-vs-Asian |
2.29350000002793E-06 |
| Caucasian-vs-AfricanAmerican |
5.092000E-01 |
| Caucasian-vs-Asian |
6.613900E-02 |
| AfricanAmerican-vs-Asian |
6.139400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.31989999999183E-05 |
| Normal-vs-Female |
2.93579999999238E-06 |
| Male-vs-Female |
8.085800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.599680E-04 |
| Normal-vs-Age(41-60Yrs) |
5.57589999949926E-07 |
| Normal-vs-Age(61-80Yrs) |
3.06090000001813E-06 |
| Normal-vs-Age(81-100Yrs) |
2.294200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.910400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.249180E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.436000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.358600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.564620E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.944400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.934400E-01 |
| Classical-VS-Follicular |
1.23234755733392E-14 |
| Classical-VS-Other |
4.919000E-01 |
| Classical-VS-Normal |
2.638800E-04 |
| Tall-VS-Follicular |
3.036000E-04 |
| Tall-VS-Other |
4.746000E-01 |
| Tall-VS-Normal |
4.370000E-02 |
| Follicular-VS-Other |
2.834800E-01 |
| Follicular-VS-Normal |
8.66229310503286E-12 |
| Other-VS-Normal |
5.565900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.32549999976028E-07 |
| Normal-vs-N1 |
3.98860000000445E-05 |
| N0-vs-N1 |
4.123200E-01 |
|
|
